These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 329737

  • 1. [Aprindine in oral long-term preventive treatment of recurrent ventricular tachycardia (author's transl)].
    Frank R, Fournial JF, Vedel J, Fontaine G, Dragodanne C, Grosgogeat Y.
    Ann Cardiol Angeiol (Paris); 1977; 26(4):335-8. PubMed ID: 329737
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF, Martín Sánchez JC, Ciscar A, Hidalgo M, Petit Guinovart M, Ballesta Barcons F.
    Rev Esp Cardiol; 1975; 38(2):145-52. PubMed ID: 49071
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
    Fasola AF, Noble RJ, Zipes DP.
    Am J Cardiol; 1977 May 26; 39(6):903-9. PubMed ID: 67800
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of extrasystoles using a new oral anti-arrhythmic agent Aprindine].
    Sterz H.
    Acta Med Austriaca; 1974 May 26; 1(4):127-31. PubMed ID: 4142916
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Study of aprindine in the treatment of ventricular arrhythmia. Control by multiple long duration ECG recordings (author's transl)].
    Medvedowsky JL, Barnay C, Massat C, Hanvic G.
    Ann Cardiol Angeiol (Paris); 1980 May 26; 29(3):201-9. PubMed ID: 7447340
    [No Abstract] [Full Text] [Related]

  • 11. [Anti-arrhythmic effects of injectable aprindine in the dog].
    Cheymol G, Gilbert JC, Mouillé P.
    Therapie; 1974 May 26; 29(5):719-30. PubMed ID: 4549334
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The effect of mexiletine, ajmaline and aprindine on ventricular arrhythmias].
    Pozenel H.
    Adv Clin Pharmacol; 1978 May 26; 16():125-37. PubMed ID: 356551
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of aprindine on the induction and termination of supraventricular tachycardia in patients with accessory pathway syndrome].
    Kubota K, Ikeda T, Takata S, Murakami T, Nakamura S, Fujiki A, Higashino A, Hattori N.
    Kokyu To Junkan; 1985 Jul 26; 33(7):913-9. PubMed ID: 4059681
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].
    Hagemeijer F, Janse C, Hugenholtz PG.
    Acta Cardiol; 1974 Jul 26; Suppl 18():409-21. PubMed ID: 4138502
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL, Ambrosioni E, Bracchetti D, Magnani B.
    Int J Clin Pharmacol Biopharm; 1979 Oct 26; 17(10):396-403. PubMed ID: 500254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.